Changes in serum levels of M30,M65,and IL-17 and their clinical significance in patients with acute pancreatitis

Hao TingTing; Ma XiaoPeng; Wen YanLi; Dai GuangRong; Feng YiChao; Zhang Li

doi:10.3969/j.issn.1001-5256.2016.02.027

Issue 2

Feb. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(2): 329-332

PDF( 1824 KB)

Changes in serum levels of M30,M65,and IL-17 and their clinical significance in patients with acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2016.02.027

Department of Gastroenterology,Yan' an University Affiliated Hosital

Received Date: 2015-07-08
Published Date: 2016-02-20

Abstract

Abstract

Objective To investigate the changes in serum levels of M30,M65,and interleukin- 17( IL- 17) and their clinical significance in patients with acute pancreatitis. Methods A total of 126 patients with acute pancreatitis who were admitted to our hospital from December 2009 to December 2013 were selected,and according to clinical diagnosis,they were divided into mild acute pancreatitis group( 82 patients) and severe acute pancreatitis group( 44 patients). A total of 107 healthy subjects who underwent physical examination during the same period of time were enrolled as the control group. On days 1,2,and 4,the serum levels of M30,M65,and IL- 17 were measured,and M30 / M65 ratio was calculated. Comparison of coutinous data between multiple groups was made by ANOVA and pairwise comparison between any two groups was made by SNK- q test,comparison between two groups was made by independent- sample t test,while comparison of categorical data by chisquare test. Results On days 1,2,and 4,the severe acute pancreatitis group and mild acute pancreatitis group had significantly higher serum levels of M30,M65,and IL- 17( P < 0. 05),and a significantly lower M30 / M65 ratio( P <0. 001),as compared with the healthy controls. On days 1,2,and 4,the severe acute pancreatitis group had significantly higher serum levels of M30 and M65 than the mild acute pancreatitis group( P < 0. 001); on day 1,the severe acute pancreatitis group had a significantly lower M30 / M65 ratio than the mild acute pancreatitis group( P < 0. 001); the serum level of IL- 17 showed no significant difference between the two groups( P > 0. 05). M65 and IL- 17 had high sensitivity and specificity in the diagnosis of acute pancreatitis. Conclusion The serum levels of M65 and IL- 17 and M30 / M65 ratio at 24 hours after the attack of acute pancreatitis can be used as the serological biomarkers for early evaluation of the severity of acute pancreatitis.
- pancreatitis,
- keratin-18,
- interleukin-17,
- early diagnosis

FullText(HTML)

References(15)

References

[1]BANKS PA,FREEMAN ML.Practice guidelines in acute pancreatitis[J].Am J Gastroenterol,2006,101(10):2379-2400.

[2]PONGPRASOBCHAI S,JIANJAROONWONG V,CHARATCHAROENWITTHAYA P,et al.Erythrocyte sedimentation rate and C-reactive protein for the prediction of severity of acute pancreatitis[J].Pancreas,2010,39(8):1226-1230.

[3]GUKOVSKAYA AS,PANDOL SJ.Cell death pathways in pancreatitis and pancreatic cancer[J].Pancreatology,2004,4(6):567-586.

[4]NUEZ G,BENEDICT MA,HU Y,et al.Caspases:the proteases of the apoptotic pathway[J].Oncogene,1998,17(25):3237-3245.

[5]CAULIN C,SALVESEN GS,OSHIMA RG.Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis[J].J Cell Biol,1997,138(6):1379-1394.

[6]CRAIG DG,LEE P,PRYDE EA,et al.Circulating apoptotic and necrotic cell death markers in patients with acute liver injury[J].Liver Int,2011,31(8):1127-1136.

[7]BANCHEREAU J,PASCUAL V,O'GARRA A.From IL-2 to IL-37:the expanding spectrum of anti-inflammatory cytokines[J].Nat Immunol,2012,13(10):925-931.

[8]Pancreas Study Group,Chinese Society of Gastroenterology,Chinese Medical Association.Chinese guidelines for the management of acute pancreatitis(draft)[J].Chin J Int Med,2004,43(3):236-238.(in Chinese)中华医学会消化病学分会胰腺疾病学组.中国急性胰腺炎诊治指南(草案)[J].中华内科杂志,2004,43(3):236-238.

[9]BANKS PA,FREEMAN ML.Pratice guidelines in acute pancreatitis[J].AM J Gastroenterol,2006,101(10):2379-2400.

[10]BARRETO SG,RODRIGUES J.Comparison of APACHEⅡand Imrie Scoring Systems in predicting the severity of acute pancreatitis[J].World J Emerg Surg,2007,2:33.

[11]BCHLER M,MALFERTHEINER P,SCHOETENSACK C,et al.Sensitivity of antiproteases,complement factors and C-reactive protein in detecting pancreatic necrosis.Results of a prospective clinical study[J].Int J Pancreatol,1986,1(3-4):227-235.

[12]NEOPTOLEMOS JP,KEMPPAINEN EA,MAYER JM,et al.Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide:a multicentre study[J].Lancet,2000,355(9219):1955-1960.

[13]SUNG KF,ODINOKOVA IV,MARENINOVA OA,et al.Prosurvival Bcl-2 proteins stabilize pancreatic mitochondria and protect against necrosis in experimental pancreatitis[J].Exp Cell Res,2009,315(11):1975-1989.

[14]SCHUTTE B,HENFLING M,KLGEN W,et al.Keratin 8/18breakdown and reorganization during apoptosis[J].Exp Cell Res,2004,297(1):11-26.

[15]MIOSSEC P,KOLLS JK.Targeting IL-17 and TH17 cells in chronic inflammation[J].Nat Rev Drug Discov,2012,11(10):763-776.

Relative Articles

[1]	Liu Li, Jiang YingYi, Liu Jing. Glucose metabolism and insulin secretion in patients with chronic hepatitis B cirrhosis of different Child-Pugh grades and their association with inflammatory response[J]. Journal of Clinical Hepatology, 2020, 36(2): 324-328. doi: 10.3969/j.issn.1001-5256.2020.02.018
[2]	Wu QiQi, Ma Yan, Wang XiaoBo, Xu Qiang, Wang Yan, Bai Li. Influence of metabolic syndrome on significant hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(12): 2572-2577. doi: 10.3969/j.issn.1001-5256.2018.12.013
[3]	He YuLan, Sun Lin, Yu HongWei, Meng QingHua. Expression of glucose transporter 2 in liver tissue in patients with hepatogenous diabetes and its significance[J]. Journal of Clinical Hepatology, 2017, 33(3): 512-515. doi: 10.3969/j.issn.1001-5256.2017.03.023
[4]	Li Qiang, Zhuo QiBin, Huang YuXian, Chen Liang. Clinical features of acute hepatitis B and acute exacerbation of chronic hepatitis B: a comparative study[J]. Journal of Clinical Hepatology, 2016, 32(4): 706-710. doi: 10.3969/j.issn.1001-5256.2016.04.019
[5]	Ruan JianWen, Gao LiJuan, Su RuKai. Clinical features of patients with acute exacerbation of chronic hepatitis B: an analysis of 74 cases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2096-2098. doi: 10.3969/j.issn.1001-5256.2016.11.017
[6]	Xun YunHao, Guo JianChun. Clinical application of traditional Chinese medicine constitution theory in diagnosis and treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(4): 644-648. doi: 10.3969/j.issn.1001-5256.2016.04.006
[7]	Zhang ZeTian, Ji HuiFan, Chen Shuai, Li Xu, Yang WenXuan, Zhang GuoShan, Guo XiaoLin. Clinical cure of chronic hepatitis B: a case report[J]. Journal of Clinical Hepatology, 2016, 32(8): 1578-1579. doi: 10.3969/j.issn.1001-5256.2016.08.030
[8]	Zhang WenJie, Chen QiDan, Wan Yu, Deng Hui. Clinical features of male patients with alcoholic liver cirrhosis or hepatitis B cirrhosis complicated by abnormal glucose metabolism[J]. Journal of Clinical Hepatology, 2016, 32(2): 296-300. doi: 10.3969/j.issn.1001-5256.2016.02.020
[9]	Gao YueQiu. Strategy for traditional Chinese medicine prevention and treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(1): 35-37. doi: 10.3969/j.issn.1001-5256.2015.01.008
[10]	Peng Hong, Yang Jian, Mai RunZhang, Chen HongTao. Relationship between serum adiponectin level and metabolic indices in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(4): 354-356. doi: 10.3969/j.issn.1001-5256.2014.04.016
[11]	Zhang LiHang, Mao JunLing, Ren HaiFeng, Wang ShanJuan, Zhang Hui, Wan Jian, Liu YanLi, Wang YiFei, Lin YongHui. Relationship between glucose metabolism and hepatic encephalopathy in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(7): 532-534. doi: 1001-5256 (2013) 07-0532-03
[12]	Hepatobiliary Disease Group, Internal Medicine of Traditional Chinese, China Association of Traditional Chinese Medicine, Expert Consensus of Hepatology, World Federation of Chinese Medicine Societies, Hepatology Group, Chinese Association of the Integration of Traditional and Western Medicine. Guidelines for traditional Chinese medical diagnosis of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2012, 28(3): 164-168.
[13]	Zhu QiRong. Nosocomial infections and chronic severe hepatitis B: A clinical study of 162 patients[J]. Journal of Clinical Hepatology, 2012, 28(7): 525-527.
[14]	Li ChunXia, Pan HuaiQiang, Li YanJun, Xu GuangHua, Chen YanPing, Feng JiHong, Wei Hua, Ceng QingLei. One case report of occult hepatitis B infection[J]. Journal of Clinical Hepatology, 2012, 28(1): 66-68.
[15]	Yang Song, Cheng Jun. Interpretation of Chinese guideline on prevention and treatment for chronic hepatitis B (2011version) -status quo and prospect of antiviral therapy[J]. Journal of Clinical Hepatology, 2011, 27(8): 794-795+800.
[16]	Qiu YingFeng, Ding YongGang, Li GuangMing. Analysis of therapeutic effect of adefovir dipivoxil in continued treatment of chronic hepatitis B patients with poor early virological response to initial treatment[J]. Journal of Clinical Hepatology, 2011, 27(6): 611-613.
[17]	Huang WeiShen, Yang Li. Predicting scoring system for hepatocellular carcinoma development in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2011, 27(4): 363-364.
[18]	Li Hai, Jia JiDong. Interpretation of the guideline on prevention and treatment for chronic hepatitis B (2010 version) -the goals and indications for chronic hepatitis B treatment[J]. Journal of Clinical Hepatology, 2011, 27(8): 791-793.
[19]	Jin QingLong, Wang ZhongFeng, Yan HongQing, Niu JunQi. The study of the change in creatine kinase in patients with chronic hepatitis B during the antiviral treatment with Telbivudine and Lamivudine[J]. Journal of Clinical Hepatology, 2011, 27(2): 143-144+156.
[20]	Li Zhi, Yan HongMei, Xue FaXuan, Wang Tong, Liang Qun, Xu Huan, Li ZhangChun. Short-term clinical effect of telbivudine in the treatment chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(6): 420-421+426.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2455) PDF downloads(450)

Changes in serum levels of M30,M65,and IL-17 and their clinical significance in patients with acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2016.02.027

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Changes in serum levels of M30,M65,and IL-17 and their clinical significance in patients with acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2016.02.027

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content